
ATHA
Athira Pharma Inc.
$0.39
-$0.01(-1.74%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$15.97M
Volume
56.01K
52W Range
$0.22 - $3.03
Target Price
$0.40
Order:
Income Statement
Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
OPERATING EXPENSES | |||||||
Operating Expenses | $20.0M | $64.0M | $88.9M | $127.1M | $96.8M | ||
Research & Development | $13.3M | $42.8M | $61.5M | $93.8M | $70.7M | ||
Research Expense | $13.3M | $42.8M | $61.5M | $93.8M | $70.7M | ||
Selling, General & Administrative | $6.7M | $21.2M | $32.6M | $33.3M | $26.1M | ||
General & Administrative Expenses | $6.7M | $21.2M | $32.6M | $33.3M | $26.1M | ||
Salaries & Wages | -- | -- | -- | $10.6M | $11.0M | ||
Depreciation & Amortization | $2.0K | $479.0K | $845.0K | $969.0K | $970.0K | ||
Depreciation & Amortization | $2.0K | $479.0K | $845.0K | $969.0K | $970.0K | ||
Other Operating Expenses | $85.0K | $323.0K | $-684.0K | $-1.5M | $-1.0M | ||
OPERATING INCOME | |||||||
Operating income | $-20.0M | $-64.0M | $-104.0M | $-125.5M | $-100.9M | ||
EBITDA | $-19.6M | $-54.7M | $-88.0M | $-116.5M | $-95.7M | ||
NON-OPERATING ITEMS | |||||||
Interest Expense (Non-Operating) | $367.0K | $3.0K | -- | -- | -- | ||
Intinc | $124.0K | $337.0K | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-243.0K | $334.0K | -- | -- | -- | ||
Other Income/Expense | $1.3M | $-334.0K | $-6.8M | $-7.6M | $-4.0M | ||
Other Special Charges | $-1.3M | $334.0K | $3.2M | $7.6M | $4.0M | ||
SPECIAL ITEMS | |||||||
Restructring And Mn A Income | -- | -- | -- | -- | $2.9M | ||
Special Income Charges | -- | -- | $-10.0M | $1.6M | $-4.1M | ||
PRE-TAX INCOME | |||||||
EBIT | $-19.6M | $-55.2M | $-88.9M | $-117.7M | $-96.9M | ||
Pre-Tax Income | $-21.3M | $-63.7M | $-95.6M | $-117.8M | $-96.9M | ||
NET INCOME | |||||||
Net Income | $-20.0M | $-54.9M | $-95.6M | $-117.7M | $-96.9M | ||
Net Income (Continuing Operations) | $-20.0M | $-54.9M | $-95.6M | $-117.7M | $-96.9M | ||
Net Income (Discontinued Operations) | $-20.0M | $-54.9M | $-95.6M | $-117.7M | $-96.9M | ||
Net Income (Common Stockholders) | $-20.0M | $-55.3M | $-95.6M | $-117.7M | $-96.9M | ||
Normalized Income | -- | -- | -- | -- | $-89.0M | ||
TOTALS | |||||||
Total Expenses | $20.0M | $64.0M | $88.9M | $127.1M | $96.8M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $12.0M | $36.9M | $37.7M | $38.0M | $38.5M | ||
Average Shares Outstanding (Diluted) | $12.0M | $36.9M | $37.7M | $38.0M | $38.5M | ||
Shares Outstanding | $37.1M | $37.6M | $37.9M | $38.3M | $39.0M | ||
Basic EPS | $-1.67 | $-1.49 | $-2.53 | $-3.09 | $-2.52 | ||
Basic EPS (Continuing Operations) | $-1.67 | $-1.49 | $-2.53 | $-3.09 | $-2.52 | ||
Diluted EPS | $-1.67 | $-1.49 | $-2.53 | $-3.09 | $-2.52 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-2.53 | $-3.09 | $-2.52 | ||
OTHER METRICS | |||||||
Net Income From Other Gains Losses | $1.3M | $8.8M | $5.2M | -- | -- | ||
Non Recurring Operation Expense | -- | -- | $10.0M | $-1.6M | $4.1M | ||
Other Gand A | $6.7M | $21.2M | $32.6M | $33.3M | $26.1M | ||
Restruct | -- | -- | -- | -- | $2.9M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ATHA | $0.39 | -1.7% | 56.01K |
3 | ||||
4 | ||||
5 | ||||
6 |